Stefan Kubick

Dr. Stefan Kubick

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2015 in ChemBioChem
Verified
Journal Article
Open access
PDF file
AZAnne Zemella
Anne Zemella
LTLena Thoring
Lena Thoring
CHChristian Hoffmeister
Christian Hoffmeister
SKStefan Kubick
Stefan Kubick
From its start as a small‐scale in vitro system to study fundamental translation processes, cell‐free protein synthesis quickly rose to become a potent platform for the high‐yield production of proteins. In contrast to classical in vivo protein expression, cell‐free systems do not need time‐consuming cloning steps, and the open nature provides easy manipulation of reaction conditions as well as high‐throughput potential. Especially for the synthesis of difficult to express proteins, such as toxic and transmembrane proteins, cell‐free systems are of enormous interest. The modification of the genetic code to incorporate non‐canonical amino acids into the target protein in particular provides enormous potential in biotechnology and pharmaceutical research and is in the focus of many cell‐free projects. Many sophisticated cell‐free systems for manifold applications have been established. This review describes the recent advances in cell‐free protein synthesis and details the expanding applications in this field.

12 June 2014 in FEBS Letters
Verified
Journal Article
Open access
RSRita Sachse
Rita Sachse
SDSrujan K. Dondapati
Srujan K. Dondapati
SFSusanne F. Fenz
Susanne F. Fenz
TSThomas Schmidt
Thomas Schmidt
SKStefan Kubick
Stefan Kubick
When taking up the gauntlet of studying membrane protein functionality, scientists are provided with a plethora of advantages, which can be exploited for the synthesis of these difficult‐to‐express proteins by utilizing cell‐free protein synthesis systems. Due to their hydrophobicity, membrane proteins have exceptional demands regarding their environment to ensure correct functionality. Thus, the challenge is to find the appropriate hydrophobic support that facilitates proper membrane protein folding. So far, various modes of membrane protein synthesis have been presented. Here, we summarize current state‐of‐the‐art methodologies of membrane protein synthesis in biomimetic‐supported systems. The correct folding and functionality of membrane proteins depend in many cases on their integration into a lipid bilayer and subsequent posttranslational modification. We highlight cell‐free systems utilizing the advantages of biological membranes.

20 March 2020 in BioDrugs
Verified
Journal Article
Open access
PDF file
SDSrujan Kumar Dondapati
Srujan Kumar Dondapati
MSMarlitt Stech
Marlitt Stech
AZAnne Zemella
Anne Zemella
SKStefan Kubick
Stefan Kubick
Proteins are the main source of drug targets and some of them possess therapeutic potential themselves. Among them, membrane proteins constitute approximately 50% of the major drug targets. In the drug discovery pipeline, rapid methods for producing different classes of proteins in a simple manner with high quality are important for structural and functional analysis. Cell-free systems are emerging as an attractive alternative for the production of proteins due to their flexible nature without any cell membrane constraints. In a bioproduction context, open systems based on cell lysates derived from different sources, and with batch-to-batch consistency, have acted as a catalyst for cell-free synthesis of target proteins. Most importantly, proteins can be processed for downstream applications like purification and functional analysis without the necessity of transfection, selection, and expansion of clones. In the last 5 years, there has been an increased availability of new cell-free lysates derived from multiple organisms, and their use for the synthesis of a diverse range of proteins. Despite this progress, major challenges still exist in terms of scalability, cost effectiveness, protein folding, and functionality. In this review, we present an overview of different cell-free systems derived from diverse sources and their application in the production of a wide spectrum of proteins. Further, this article discusses some recent progress in cell-free systems derived from Chinese hamster ovary and Sf21 lysates containing endogenous translocationally active microsomes for the synthesis of membrane proteins. We particularly highlight the usage of internal ribosomal entry site sequences for more efficient protein production, and also the significance of site-specific incorporation of non-canonical amino acids for labeling applications and creation of antibody drug conjugates using cell-free systems. We also discuss strategies to overcome the major challenges involved in commercializing cell-free platforms from a laboratory level for future drug development.

15 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LTLena Thoring
Lena Thoring
SDSrujan K. Dondapati
Srujan K. Dondapati
MSMarlitt Stech
Marlitt Stech
DWDoreen A. Wüstenhagen
Doreen A. Wüstenhagen
SKStefan Kubick
Stefan Kubick
Cell-free protein synthesis (CFPS) represents a promising technology for efficient protein production targeting especially so called “difficult-to-express” proteins whose synthesis is challenging in conventional in vivo protein production platforms. Chinese hamster ovary (CHO) cells are one of the most prominent and safety approved cell lines for industrial protein production. In this study we demonstrated the ability to produce high yields of various protein types including membrane proteins and single chain variable fragments (scFv) in a continuous exchange cell-free (CECF) system based on CHO cell lysate that contains endogenous microsomal structures. We showed significant improvement of protein yield compared to batch formatted reactions and proved biological activity of synthesized proteins using various analysis technologies. Optimized CECF reaction conditions led to membrane protein yields up to 980 µg/ml, which is the highest protein yield reached in a microsome containing eukaryotic cell-free system presented so far.

20 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSM. Stech
M. Stech
ONO. Nikolaeva
O. Nikolaeva
LTL. Thoring
L. Thoring
WSW. F. M. Stöcklein
W. F. M. Stöcklein
DWD. A. Wüstenhagen
D. A. Wüstenhagen
SKStefan Kubick
Stefan Kubick
Antibodies are indispensable tools for basic research as well as diagnostic and therapeutic applications. Consequently, the development of alternative manufacturing strategies which circumvent the hurdles connected to conventional antibody production technologies is of enormous interest. To address this issue, we demonstrate the synthesis of complex antibody formats, in particular immunoglobulin G (IgG) and single-chain variable fragment Fc fusion (scFv-Fc), in a microsome-containing cell-free system based on translationally active chinese hamster ovary (CHO) cell lysates. To mimic the environment for antibody folding and assembly present in living cells, antibody genes were fused to an endoplasmic reticulum (ER)-specific signal sequence. Signal-peptide induced translocation of antibody polypeptide chains into the lumen of ER microsomes was found to be the prerequisite for antibody chain assembly and functionality. In this context, we show the rapid synthesis of antibody molecules in different reaction formats, including batch and continuous-exchange cell-free (CECF) reactions, depending on the amount of protein needed for further analysis. In addition, we demonstrate site-specific and residue-specific labeling of antibodies with fluorescent non-canonical amino acids. In summary, our study describes a novel antibody production platform which combines the highly efficient mammalian protein folding machinery of CHO cells with the benefits of cell-free protein synthesis.

1 May 2015 in FEBS Letters
Verified
Journal Article
Open access
RQRobert B. Quast
Robert B. Quast
DMDevid Mrusek
Devid Mrusek
CHChristian Hoffmeister
Christian Hoffmeister
ASAndrei Sonnabend
Andrei Sonnabend
SKStefan Kubick
Stefan Kubick
Over the last years protein engineering using non‐standard amino acids has gained increasing attention. As a result, improved methods are now available, enabling the efficient and directed cotranslational incorporation of various non‐standard amino acids to equip proteins with desired characteristics. In this context, the utilization of cell‐free protein synthesis is particularly useful due to the direct accessibility of the translational machinery and synthesized proteins without having to maintain a vital cellular host. We review prominent methods for the incorporation of non‐standard amino acids into proteins using cell‐free protein synthesis. Furthermore, a list of non‐standard amino acids that have been successfully incorporated into proteins in cell‐free systems together with selected applications is provided.